Reported 982,196 shares, up 978,167 (24278.2%) from the prior quarter.
Reported value 24648.4%; share count 24278.2% vs. the prior quarter.
Reported position value by quarter
Each bar is a Form 13-F quarter-end snapshot. It does not show trades made within the quarter.
| Date | Holding Value |
|---|---|
| 2025-12-31 | 54513205 |
| 2026-03-31 | 59746248 |
| 2026-06-30 | 398936 |
| 2026-09-30 | 98730314 |
Quarterly position history
How this manager's reported quarter-end position changed over time.
| Quarter | Activity | Shares | Change | % of reported 13F | Reported value | Filed | Source filing |
|---|---|---|---|---|---|---|---|
| Q3 2026 | Added | 982,196 | +978,167 (24278.2%) | 0.98% | $98,730,314 | 2026-11-12 | |
| Q2 2026 | Reduced | 4,029 | -685,245 (-99.4%) | < 0.01% | $398,936 | 2026-08-14 | |
| Q1 2026 | Added | 689,274 | +46,657 (7.3%) | 0.74% | $59,746,248 | 2026-05-11 | |
| Q4 2025 | New | 642,617 | +642,617 (0.0%) | 0.71% | $54,513,205 | 2026-02-10 |
Who else reported the position
270 managers reported ISHARES for Q3 2026.
| Manager | Activity | Shares | Change | % of reported 13F | Reported value | Tenure |
|---|---|---|---|---|---|---|
| Fisher Asset Management LLC | Reduced | 2,704,418 | -28,419 | 0.08% | $271,848,173 | 30 qtrs |
| Foundations Investment Advisors LLC This report | Added | 982,196 | +978,167 | 0.98% | $98,730,314 | 4 qtrs |
| MORGAN STANLEY | Added | 882,272 | +424,649 | < 0.01% | $88,686,160 | 54 qtrs |
| Bank of America Corporation | Reduced | 578,702 | -284,011 | < 0.01% | $58,171,122 | 54 qtrs |
| JPMorgan Chase & Co | Reduced | 430,242 | -123,570 | < 0.01% | $43,996,679 | 51 qtrs |
| MML INVESTORS SERVICES LLC | Added | 418,061 | +408,850 | 0.13% | $42,023,519 | 11 qtrs |
| TD Asset Management Inc | Added | 320,547 | +128,047 | 0.03% | $32,779,136 | 2 qtrs |
| MinichMacGregor Wealth Management LLC | New | 319,306 | +319,306 | 5.18% | $32,098,321 | 1 qtr |
| LPL Financial LLC | Added | 311,911 | +80,986 | < 0.01% | $31,353,325 | 54 qtrs |
| Horizon Investments LLC | New | 305,190 | +305,190 | 0.27% | $30,677,699 | 1 qtr |
Filing details and methodology As reported
- Report period
- September 30, 2026
- Filed
- November 12, 2026
- Filing type
- 13F-HR
- Position type
- U.S. PHARMA ETF
Voting authority reported
- Sole
- 0
- Shared
- 0
- None
- 982,196
“None” means the manager reported no voting authority for those shares on non-routine matters. It does not disclose why and is not evidence of securities lending.
Form 13-F is a delayed quarter-end snapshot of disclosed long Section 13(f) securities. It can be filed up to 45 days after quarter end, excludes short positions and most non-U.S. securities, and does not reveal intra-quarter trading. For options, reported shares and value describe the underlying-share exposure; strike, expiry, premium, and written positions are not disclosed.